Form 8-K IOVANCE BIOTHERAPEUTICS, For: May 18
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Iovanace Biotherapeutics (IOVA) Has Strong Cash Cushion Even as CEO Exit Adds to Uncertainties - Mizuho
May 19, 2021 12:42 PM EDTMizuho Securities analyst Mara Goldstein weighed in on Iovanace Biotherapeutics (NASDAQ: IOVA) after the company announced that Maria Fardis, Ph.D. will resign as President and CEO of the company following today's regulatory setback.
"The commercial potential for lifileucel remains but the question... More
Iovance Biotherapeutics (IOVA) Halted on LUDP
May 19, 2021 12:01 PM EDTIovance Biotherapeutics (NASDAQ: IOVA) Halted on LUDP
Iovance Biotherapeutics (IOVA) CEO Resigns
May 19, 2021 12:01 PM EDTIovance Biotherapeutics (NASDAQ: IOVA) disclosed:
On May 18, 2021, Maria Fardis, Ph.D., the Chief Executive Officer (CEO) of Iovance Biotherapeutics, Inc. (the Company), notified the Company that she will be resigning as President, CEO and a director of the Company to pursue other opportunities. The... More
